CCR5 antagonism in HIV infection: ways, effects, and side effects

被引：34

作者：

Corbeau, Pierre ^{[2
,3
,4
]}

Reynes, Jacques ^{[1
,4
,5
]}

机构：

[1] CHU Montpellier, Serv Malad Infect & Trop, Montpellier, France

[2] CHU Nimes, Unite Fonctionnelle Immunol, Nimes, France

[3] CNRS, Inst Genet Humaine, UPR1142, F-75700 Paris, France

[4] Univ Montpellier I, Fac Med, F-34006 Montpellier, France

[5] UMR145, Montpellier, France

来源：

AIDS | 2009年 / 23卷 / 15期

关键词：

HUMAN-IMMUNODEFICIENCY-VIRUS; CHEMOKINE RECEPTOR CCR5; T-LYMPHOCYTE ACTIVATION; BETA-CHEMOKINES; IN-VIVO; MONOCLONAL-ANTIBODY; CLINICAL-TRIALS; DOWN-REGULATION; UP-REGULATION; R5; STRAINS;

D O I：

10.1097/QAD.0b013e32832e71cd

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1931 / 1943

页数：13

共 178 条

[1] Adaptation to blockade of human immunodeficiency virus type 1 entry imposed by the anti-CCR5 monoclonal antibody 2D7 [J].

Aarons, EJ ;

Beddows, S ;

Willingham, T ;

Wu, LJ ;

Koup, RA .

VIROLOGY, 2001, 287 (02) :382-390

[2]

Abdi R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133754

[3] Role for CCR5Δ32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells [J].

Agrawal, L ;

Lu, XH ;

Qingwen, J ;

VanHorn-Ali, Z ;

Nicolescu, IV ;

McDermott, DH ;

Murphy, PM ;

Alkhatib, G .

JOURNAL OF VIROLOGY, 2004, 78 (05) :2277-2287

[4] Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5 [J].

Agrawal, L ;

VanHorn-Ali, Z ;

Berger, EA ;

Alkhatib, G .

BLOOD, 2004, 103 (04) :1211-1217

[5] Effects of the CCR5-Δ32 mutation on antiviral treatment in chronic hepatitis C [J].

Ahlenstiel, G ;

Berg, T ;

Woitas, RP ;

Grünhage, F ;

Iwan, A ;

Hess, L ;

Brackmann, HH ;

Kupfer, B ;

Schernick, A ;

Sauerbruch, T ;

Spengler, U .

JOURNAL OF HEPATOLOGY, 2003, 39 (02) :245-252

[6] Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells [J].

Alberti, J ;

Valenzuela, JG ;

Carruthers, VB ;

Hieny, S ;

Andersen, J ;

Charest, H ;

Sousa, CRE ;

Fairlamb, A ;

Ribeiro, JM ;

Sher, A .

NATURE IMMUNOLOGY, 2003, 4 (05) :485-490

[7] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].

Alkhatib, G ;

Combadiere, C ;

Broder, CC ;

Feng, Y ;

Kennedy, PE ;

Murphy, PM ;

Berger, EA .

SCIENCE, 1996, 272 (5270) :1955-1958

[8] Escape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a fitness loss [J].

Anastassopoulou, Cleo G. ;

Marozsan, Andre J. ;

Matet, Alexandre ;

Snyder, Amy D. ;

Arts, Eric J. ;

Kuhmann, Shawn E. ;

Moore, John P. .

PLOS PATHOGENS, 2007, 3 (06) :720-732

[9] Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis:: Lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine [J].

Andres, PG ;

Beck, PL ;

Mizoguchi, E ;

Mizoguchi, A ;

Bhan, AK ;

Dawson, T ;

Kuziel, WA ;

Maeda, N ;

MacDermott, RP ;

Podolsky, DK ;

Reinecker, HC .

JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6303-6312

[10] Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue [J].

Anton, PA ;

Elliott, J ;

Poles, MA ;

McGowan, IM ;

Matud, J ;

Hultin, LE ;

Grovit-Ferbas, K ;

Mackay, CR ;

Chen, ISY ;

Giorgi, JV .

AIDS, 2000, 14 (12) :1761-1765

← 1 2 3 4 5 6 7 8 9 10 →